Doxepin hydrochloride

Pricing Availability Delivery Time Qty
Cat.No. 0508 - Doxepin hydrochloride | C19H21NO.HCl | CAS No. 1229-29-4
Description: Highly potent H1 antagonist. Also binds to H4 receptor
Chemical Name: 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin hydrochloride
Purity: ≥99% (HPLC)
Datasheet
Citations
Literature

Biological Activity

Highly potent H1 histamine receptor antagonist (Kd = 310 pM) and tricyclic antidepressant. Also binds to the H4 histamine receptor (pKi = 6.79).

Technical Data

M. Wt 315.84
Formula C19H21NO.HCl
Storage Store at RT
Purity ≥99% (HPLC)
CAS Number 1229-29-4
PubChem ID 5281088
InChI Key MHNSPTUQQIYJOT-CULRIWENSA-N
Smiles Cl[H].CN(C)CC\C=C1\C2=C(COC3=C1C=CC=C3)C=CC=C2

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 31.58 100
water 31.58 100

Preparing Stock Solutions

The following data is based on the product molecular weight 315.84. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.17 mL 15.83 mL 31.66 mL
5 mM 0.63 mL 3.17 mL 6.33 mL
10 mM 0.32 mL 1.58 mL 3.17 mL
50 mM 0.06 mL 0.32 mL 0.63 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References

References are publications that support the products' biological activity.

Lurchins (1983) Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants. Am.J.Psychiatry 140 1006 PMID: 6346907

Nguyen et al (2001) Discovery of a novel member of the histamine receptor family. Mol.Pharmacol. 59 427 PMID: 11179435

Tran et al (1981) [3H]Doxepin interactions with histamine H1-receptors and other sites in guinea pig brain homogenates. Eur.J.Pharmacol. 70 501 PMID: 7238574

Merck Index 12 3492 PMID:


If you know of a relevant reference for Doxepin hydrochloride, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Histamine H1 Receptor Antagonists

Keywords: Doxepin hydrochloride, supplier, potent, H1, antagonists, binds, H4, Receptors, Histamine, histaminergic, Histamine, H1, Receptors, Histamine, H1, Receptors, Tocris Bioscience

Citations for Doxepin hydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for Doxepin hydrochloride. Do you know of a great paper that uses Doxepin hydrochloride from Tocris? If so please let us know.

Commented out for usability testing

Reviews

TODO: Add Reviews

Literature in this Area

GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Secretin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Histamine Receptors

Histamine Receptors Scientific Review

Written by Iwan de Esch and Rob Leurs, this review provides a synopsis of the different histamine receptor subtypes and the ligands that act upon them; compounds available from Tocris are listed.

Asthma

Asthma Poster

Asthma is one of the most common chronic diseases in the world, affecting over 300 million people. This poster highlights key pathways and new therapies used to treat the condition, including those currently in clinical development.

Pathways for Doxepin hydrochloride

Protocols

TODO: Add Protocols